Company aTyr Pharma, Inc. Deutsche Boerse AG
Equities
471A
US0021202025
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.605 EUR | -0.93% | -12.90% | +25.58% |
Business Summary
Number of employees: 58
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Medicines
100.0
%
| 10 | 100.0 % | 0 | 100.0 % | -96.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 0 | 100.0 % | -96.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/16/30 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 30/18/30 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Ashlee Dunston
IRC | Investor Relations Contact | - | 01/20/01 |
Peter Villiger
PRN | Corporate Officer/Principal | - | 01/16/01 |
Human Resources Officer | - | 24/21/24 | |
General Counsel | - | 06/21/06 | |
Leslie Nangle
PRN | Corporate Officer/Principal | - | - |
Nancy Krueger
LAW | General Counsel | 56 | 01/14/01 |
Andrew B. Cubitt
PRN | Corporate Officer/Principal | - | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 08/05/08 |
Tim Coughlin
CHM | Chairman | 57 | 10/17/10 |
John Clarke
BRD | Director/Board Member | 70 | 01/05/01 |
Sara Zaknoen
BRD | Director/Board Member | 65 | 25/21/25 |
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/16/30 |
Jane Gross
BRD | Director/Board Member | 67 | 28/19/28 |
Svetlana Lucas
BRD | Director/Board Member | 52 | 28/19/28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,010,940 | 67,228,938 ( 97.42 %) | 0 | 97.42 % |
Company contact information
aTyr Pharma, Inc.
10240 Sorrento Valley Road Suite 300
92121, San Diego
+858 731 8389
http://www.atyrpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.59% | 63.85B | |
-1.51% | 41.83B | |
+40.85% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-20.60% | 18.69B | |
+3.01% | 12.73B | |
+22.70% | 12.11B | |
+28.41% | 12.07B |
- Stock Market
- Equities
- LIFE Stock
- 471A Stock
- Company aTyr Pharma, Inc.